Practice guide, published and reviewed on 17 November 2026. This article applies the current renewal framework to portfolio management. It does not announce a new 2026 renewal deadline or a general increase in Unitary Patent renewal fees.
Centralised renewal administration can simplify a large portfolio, but it also concentrates responsibility. A business needs to know which right is being maintained, which patent year is due and who has authority to approve the payment. The renewal reminder should trigger a documented commercial decision, not an automatic exchange of invoices whose meaning nobody has checked.
One fee, the correct patent year
The proprietor pays the Unitary Patent renewal fee to the EPO under a single payment framework. The ordinary due date is the last day of the month containing the filing-date anniversary; the grant anniversary is not the ordinary reference point. Fees generally cannot be validly paid more than three months early. Check the applicable rules and any special circumstances of the file. [1] [2] [3]
The EPO cost table gives EUR 1,175 for year ten and EUR 4,855 for year twenty. Those figures describe particular patent years, not a flat annual subscription. A meaningful forecast must therefore use the actual remaining life and the current schedule, rather than multiplying this year’s payment by an arbitrary number of years. [4]
Decide what the portfolio should retain
A Unitary Patent cannot be maintained selectively in only some of its covered states by paying fewer national fees. Its unitary character also governs lapse. That differs from managing a bundle of national parts and should be understood before the portfolio is selected at grant. Non-payment must never be used as an informal experiment with geographic pruning. [5] [6]
For each asset, assess product revenue, foreseeable competitors, licensing commitments, technical alternatives and the remaining commercial horizon. A patent that protects a replacement part or licensing stream may remain important even after the original product leaves the catalogue. Conversely, a large historical research budget does not by itself establish that every later renewal is commercially justified. Record the reasoning, decision-maker and review date.
Four practical examples
These hypothetical examples illustrate governance and budgeting; they are not client histories or advice to abandon a particular right.
1. The grant date is used for the reminder
A new administrator enters the grant anniversary into a payment calendar. A second check against the filing record reveals the discrepancy before instructions are issued. The team corrects the master record and reviews other entries created through the same import process, rather than fixing only the visible reminder.
2. Finance wants to keep only three states
The business has reduced sales in several markets and asks to retain only its core countries. Counsel explains the unitary structure and examines the full rights portfolio. The decision is then made at the correct asset level, without issuing incomplete national-payment instructions for a Unitary Patent.
3. An acquisition creates two payment agents
Seller and buyer each believe a different provider controls renewals. The closing checklist identifies the responsible payer and obtains confirmation of the next due event. The handover includes payment history, reference numbers and escalation contacts so neither duplication nor a gap is hidden behind the transfer.
4. A discontinued product still earns royalties
The product manager proposes abandoning an older patent because manufacturing has stopped. The licensing team identifies a continuing royalty arrangement and customer obligations. The renewal decision is reassessed against those commitments, with the contractual position checked before any abandonment instruction is approved.
Evidence of completion matters
An approved budget, a provider’s invoice and a completed EPO payment are different records. Reconcile the instruction with evidence of execution and keep a backup contact for absences. If a payment appears missed, assess the available procedural options immediately; do not assume that a reminder will arrive or that every loss of rights can later be reversed. The best control is a timely, traceable decision followed by verified payment.
Official sources
[1] 3.7: renewal fees · [2] 3.8: due date · [3] 3.9: early payment · [4] Unitary Patent costs · [5] Regulation 1257/2012, Article 3 · [6] 3.12: lapse
Discuss the filing, deadline and commercial objective with our patent team. Please withhold confidential technical details until the conflict check is complete.